Skip to main content
Clinical Trials/CTRI/2024/08/072539
CTRI/2024/08/072539
Not yet recruiting
Phase 4

A Clinical Study to Evaluate the 72-hour Moisturization Potential of Dabur Multiple skin Care Formulations on Healthy Human Subjects - NI

Dabur India Ltd0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Dabur India Ltd
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Pms

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Gender: Male or Female with age 18\-45, with male:female (50:50\) ratio with normal , oily (avoid acne and too much oily skin) and combination skin. 3 to 4 candidates with Sensitive skin.
  • 2\. Subjects willing to give written informed consent
  • 3\. Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
  • 4\. Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
  • 5\. Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion Criteria

  • 1\. Pregnant or nursing mothers
  • 2\.Scars, excessive terminal hair or tattoo on the studied area
  • 3\.Henna tattoo anywhere on the body (in case of studies involving hair dyes)
  • 4\.Dermatological infection or pathology on the level of studied area
  • 5\.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye)
  • 6\.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures
  • 7\.Chronic illness which may influence the outcome of the study
  • 8\.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month)
  • 9\.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials